The first-ever predictive and prognostic test

National Comprehensive Cancer Network®️ (NCCN®️)-recommended as a
risk stratification tool
for localized prostate cancer1. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer V.1.2023. ©️ National Comprehensive Cancer Network, Inc. 2022. All rights reserved. Accessed March 9, 2023. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.

The ArteraAI Prostate Test is intended to identify patients who will benefit from therapy intensification and help guide treatment decisions for men with localized prostate cancer.

Our Portal

The ArteraAI Prostate Test is a Laboratory Developed Test* that is now clinically available through a single CLIA-certified laboratory in Jacksonville, FL
Clinicians† who would like to order the ArteraAI Prostate Test can contact us at support@artera.ai
Soon after, a member of our Customer Success team will reach out to set up an account in the ArteraAI Web Portal to enable order submission
The ArteraAI Prostate Test is available for $3,873
Artera is committed to providing financial assistance for patients in need. Please contact us to determine if your patient qualifies for financial assistance
*Testing is performed by ArteraAI, located at 6800 Southpoint Pkwy Suite 950, Jacksonville, Florida 32216. The ArteraAI Prostate Test was developed and its performance characteristics were determined by ArteraAI. This Laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA ‘88) as qualified to perform high-complexity clinical laboratory testing. This test is used for clinical purposes and should not be regarded as investigational or for research. This test has not been cleared or approved by the U.S. Food and Drug Administration.
†Ordering of the ArteraAI Prostate Test is limited to clinicians whose license and scope of practice allows them to order the test.
NCCN, National Comprehensive Cancer Network.
*Testing is performed by ArteraAI, located at 6800 Southpoint Pkwy Suite 950, Jacksonville, Florida 32216. The ArteraAI Prostate Test was developed and its performance characteristics were determined by ArteraAI. This Laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA ‘88) as qualified to perform high-complexity clinical laboratory testing. This test is used for clinical purposes and should not be regarded as investigational or for research. This test has not been cleared or approved by the U.S. Food and Drug Administration.
†Ordering of the ArteraAI Prostate Test is limited to clinicians whose license and scope of practice allows them to order the test.
NCCN, National Comprehensive Cancer Network.